StonvexLoading…
StonvexStonvexStonvexCore line items from ARES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.60B | $3.88B | $3.63B | $3.06B |
Operating Income | $1.29B | $1.28B | $1.33B | $510.81M |
Net Income | $527.36M | $463.74M | $474.33M | $167.54M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $28.63B | $24.88B | $24.73B | $22.00B |
Total Liabilities | $19.93B | $17.49B | $19.71B | $17.10B |
Cash & Equivalents | $488.90M | $1.51B | $348.27M | $389.99M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 313.17M | 307.59M | 294.61M |